Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mazisotine in diabetic peripheral neuropathic pain
NCT04707157Phase 2Terminated
- Sponsor
- Eli Lilly and Company
- Start
- May 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ly3556050 in diabetic polyneuropathy (DPN), sponsored by Eli Lilly and Company. Started May 2021; status: terminated.
02
Drugs
ly3556050
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT04707157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04707157.